Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Gottesman

Showing results (181-190 of 315) with videos related to

Pageof 32
Sort By:
Experimental Cell Research|July 10, 1996
Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell linesS W Johnson, D Shen, I Pastan, et al.
Molecular Biology of the Cell|October 1, 1996
Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression systemM Ramachandra, S V Ambudkar, M M Gottesman, et al.
Gene Therapy|March 1, 2000
Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in miceT Licht, S K Goldenberg, W D Vieira, et al.
Journal of the National Cancer Institute|June 7, 1989
MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explantsH Kanamaru, Y Kakehi, O Yoshida, et al.
Cancer Research|March 1, 1985
Potentiation of cytotoxic activity of immunotoxins on cultured human cellsS Akiyama, P Seth, R Pirker, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1993
A human mitochondrial ATP-dependent protease that is highly homologous to bacterial Lon proteaseN Wang, S Gottesman, M C Willingham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapyM Suzuki, Y Sugimoto, S Tsukahara, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
2,4-Dichlorobenzyl thiocyanate, an antimitotic agent that alters microtubule morphologyI Abraham, R L Dion, D M Chi, et al.
The Journal of Biological Chemistry|March 5, 1990
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cellsY Raviv, H B Pollard, E P Bruggemann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
KT-5720 reverses multidrug resistance in variant S49 mouse lymphoma cells transduced with the human MDR1 cDNA and in human multidrug-resistant carcinoma cellsH Galski, P Lazarovici, M M Gottesman, et al.
Pageof 32

Showing results (181-190 of 315) with videos related to

Sort By:
Pageof 32
Experimental Cell Research|July 10, 1996
Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell linesS W Johnson, D Shen, I Pastan, et al.
Molecular Biology of the Cell|October 1, 1996
Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression systemM Ramachandra, S V Ambudkar, M M Gottesman, et al.
Gene Therapy|March 1, 2000
Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in miceT Licht, S K Goldenberg, W D Vieira, et al.
Journal of the National Cancer Institute|June 7, 1989
MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explantsH Kanamaru, Y Kakehi, O Yoshida, et al.
Cancer Research|March 1, 1985
Potentiation of cytotoxic activity of immunotoxins on cultured human cellsS Akiyama, P Seth, R Pirker, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1993
A human mitochondrial ATP-dependent protease that is highly homologous to bacterial Lon proteaseN Wang, S Gottesman, M C Willingham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapyM Suzuki, Y Sugimoto, S Tsukahara, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
2,4-Dichlorobenzyl thiocyanate, an antimitotic agent that alters microtubule morphologyI Abraham, R L Dion, D M Chi, et al.
The Journal of Biological Chemistry|March 5, 1990
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cellsY Raviv, H B Pollard, E P Bruggemann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
KT-5720 reverses multidrug resistance in variant S49 mouse lymphoma cells transduced with the human MDR1 cDNA and in human multidrug-resistant carcinoma cellsH Galski, P Lazarovici, M M Gottesman, et al.
Pageof 32